NephroGenex To Present At The Noble Financial Capital Markets Equity Conference

NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present a corporate overview of the Company at the Noble Financial Capital Markets Eleventh Annual Equity Conference in Sandpiper, Florida.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC